{"id":49684,"date":"2020-03-10T19:41:41","date_gmt":"2020-03-10T17:41:41","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=49684"},"modified":"2020-03-10T19:41:41","modified_gmt":"2020-03-10T17:41:41","slug":"quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/","title":{"rendered":"\u00bfQu\u00e9 papel puede desempe\u00f1ar el farmac\u00e9utico en el \u00e1mbito de los tests gen\u00e9ticos? [V\u00eddeo entrevista al dr. Manel Rabanal y la Dra. Teresa P\u00e0mpols]"},"content":{"rendered":"<p>El pasado <strong>29 de enero<\/strong> el COFB acogi\u00f3 una nueva\u00a0<strong>tertulia de actualidad<\/strong>\u00a0titulada \u201c<strong>Testamos los test gen\u00e9ticos<\/strong>\u201c. En una sesi\u00f3n moderada por Luisa Juan, vocal de An\u00e1lisis Cl\u00ednicos del COFB, los ponentes fueron el doctor\u00a0<strong>Manel Rabanal<\/strong>, jefe de la Secci\u00f3n de Vigilancia y Publicidad de los Medicamentos del <strong>Departamento de Salud de la Generalidad de Catalu\u00f1a<\/strong>, la doctora\u00a0<strong>Teresa P\u00e0mpols<\/strong>, del servicio de bioqu\u00edmica y gen\u00e9tica molecular de <strong>el Hospital Cl\u00ednic de Barcelona<\/strong> y presidenta de la comisi\u00f3n de \u00e9tica de <strong>la Asociaci\u00f3n Espa\u00f1ola de Gen\u00e9tica Humana<\/strong> <strong>(AEGH)<\/strong> y <strong>Guillermo Bagar\u00eda<\/strong>, farmac\u00e9utico comunitario y vicetesorero y responsable de Atenci\u00f3n Farmac\u00e9utica del COFB.<\/p>\n<p>Finalizado el acto, pudimos hablar con el dr. Rabanal y la Dra. P\u00e1mpulos sobre los <strong>tests farmacogen\u00e9ticos<\/strong>, el <strong>marco legal<\/strong> que les afecta y sus <strong>connotaciones \u00e9ticas<\/strong>, en el v\u00eddeo entrevista que recogemos a continuaci\u00f3n.<\/p>\n<p><iframe src=\"https:\/\/player.vimeo.com\/video\/396427836\" width=\"640\" height=\"360\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<h1><strong>Dr. Rabanal: &quot;Ser\u00eda perfecto que los farmac\u00e9uticos participaran en la farmacogen\u00e9tica en un protocolo con otros agentes sanitarios&quot;<\/strong><\/h1>\n<p>Los <strong>tests farmacogen\u00e9ticos<\/strong> \u201cson <strong>pruebas diagn\u00f3sticas<\/strong> que sirven para <strong>estudiar y evaluar<\/strong> como las <strong>variantes gen\u00e9ticas<\/strong> <strong>de los individuos influyen<\/strong> en la <strong>respuesta a los medicamentos<\/strong>\u201c. El doctor Rabanal explic\u00f3 que<strong> la farmacogen\u00e9tica<\/strong> estudia la <strong>respuesta del medicamento en funci\u00f3n del metabolismo<\/strong> de cada persona, que viene determinado por la codificaci\u00f3n gen\u00e9tica de las enzimas que participan. Para llevar a cabo estas pruebas, es necesario tener en cuenta su <strong>marco legal<\/strong>.<\/p>\n<p>Tanto el reglamento de la <strong>Uni\u00f3n Europea<\/strong>\u00a0y la <strong>ley espa\u00f1ola<\/strong> determinan las <strong>condiciones<\/strong> que deben cumplir los productos sanitarios <em>in vitro<\/em> como los <strong>criterios<\/strong> que deben cumplir las <strong>pruebas gen\u00e9ticas<\/strong>. La <strong>publicidad<\/strong> de estos tests tambi\u00e9n <strong>est\u00e1 regulada<\/strong>: \u201cLa <strong>legislaci\u00f3n actual<\/strong> es muy restrictiva con lo que es la promoci\u00f3n de este tipo de producto o servicio\u201d, explic\u00f3 el dr. Rabanal, a\u00f1adiendo que \u201ctoda la normativa va muy encaminada a <strong>prohibir expresamente la promoci\u00f3n y publicidad<\/strong> de este tipo de productos\u201d.<\/p>\n<figure id=\"attachment_50423\" aria-describedby=\"caption-attachment-50423\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200129-33.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-50423 size-large\" title=\"El dr. Manel Rabanal en un momento de su exposici\u00f3n, acompa\u00f1ado por la Dra. P\u00e1mpols (izquierda) y los miembros de la junta de gobierno del COFB, Llu\u00efsa Juan y Guillermo Bagar\u00eda (derecha). \" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200129-33-1024x683.jpg\" alt=\"El Dr. Manel Rabanal en un moment de la seva exposici\u00f3, acompanyat per la Dra. P\u00e0mpols (esquerra) i els membres de la junta de govern del COFB, Llu\u00efsa Juan i Guillermo Bagar\u00eda (dreta). \" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50423\" class=\"wp-caption-text\">El dr. Manel Rabanal en un momento de su exposici\u00f3n, acompa\u00f1ado por la Dra. P\u00e1mpols (izquierda) y los miembros de la junta de gobierno del COFB, Llu\u00efsa Juan y Guillermo Bagar\u00eda (derecha).<\/figcaption><\/figure>\n<p>En cuanto al <strong>papel del farmac\u00e9utico<\/strong>\u00a0en relaci\u00f3n con la <strong>farmacogen\u00e9tica<\/strong>, el dr. Rabanal consideraba que este profesional \u201c <strong>puede participar<\/strong>, pero <strong>no utilizando el producto<\/strong> o el servicio <strong>como un bien de consumo<\/strong>\u201c. Y a\u00f1ade que el farmac\u00e9utico es un experto \u201cen <strong>procesos patol\u00f3gicos de baja o media complejidad<\/strong>\u201c, y \u201c<strong>es en este contexto<\/strong> donde debemos situar las <strong>pruebas de farmacogen\u00e9tica<\/strong>, en <strong>el \u00e1mbito de la actuaci\u00f3n sanitaria<\/strong>&#8220;.<\/p>\n<p>Apunt\u00f3 que \u201clo que ser\u00eda perfecto es que <strong>el farmac\u00e9utico participara en la farmacogen\u00e9tica<\/strong> dentro de uno <strong>protocolo de actuaci\u00f3n<\/strong> en el que se contemplara no s\u00f3lo la actuaci\u00f3n del farmac\u00e9utico sino tambi\u00e9n la <strong>de otros agentes sanitarios<\/strong> como los <strong>m\u00e9dicos<\/strong> o los <strong>analistas cl\u00ednicos\u201d. <\/strong>En este sentido, expuso la importancia de que quedara bien definida<strong> \u201ccu\u00e1l es la utilidad de esta prueba, cu\u00e1l es la utilidad del farmac\u00e9utico comunitario al participar en esta prueba y que el farmac\u00e9utico tenga la formaci\u00f3n adecuada<\/strong> para poder participar en estas pruebas en el contexto del \u00e1mbito sanitario\u201d.<\/p>\n<h1><strong>Dra. P\u00e1mpols: \u201cEl ofrecimiento de pruebas gen\u00e9ticas sin supervisi\u00f3n m\u00e9dica ni consentimiento informado est\u00e1 en contra de las buenas pr\u00e1cticas deontol\u00f3gicas\u201d<\/strong><\/h1>\n<p>Seg\u00fan Teresa P\u00e0mpols, las <strong>pruebas gen\u00e9ticas ofrecidas directamente al consumidor<\/strong> \u201cson pruebas de que se publicitan y se ofrecen <strong>sin supervisi\u00f3n profesional<\/strong>\u201c. &quot;Hay ejemplos de todo tipo&quot;, aseguraba P\u00e0mpols, un ejemplo son las de genealog\u00eda de antepasados. Tambi\u00e9n existen con prop\u00f3sito de salud, como diagn\u00f3sticos de enfermedades o portadores, de enfermedades comunes de la vida adulta o de respuesta a los medicamentos.<\/p>\n<figure id=\"attachment_50424\" aria-describedby=\"caption-attachment-50424\" style=\"width: 620px\" class=\"wp-caption aligncenter\"><a href=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200129-21.jpg\"><img decoding=\"async\" class=\"wp-image-50424 size-large\" title=\"La Dra. Teresa P\u00e0mpols en un momento de su intervenci\u00f3n.\" src=\"https:\/\/blog.cofb.cat\/wp-content\/uploads\/2020\/03\/cofb.200129-21-1024x683.jpg\" alt=\"La Dra. Teresa P\u00e0mpols en un moment de la seva intervenci\u00f3.\" width=\"620\" height=\"414\" \/><\/a><figcaption id=\"caption-attachment-50424\" class=\"wp-caption-text\">La Dra. Teresa P\u00e0mpols en un momento de su intervenci\u00f3n.<\/figcaption><\/figure>\n<p>Estas pruebas pueden tener un <strong>impacto en la salud individual y familiar<\/strong>, adem\u00e1s de un impacto <strong>socioecon\u00f3mico<\/strong>, seg\u00fan la Dra. P\u00e1mpulos. Esto, aseguraba, lo hace <strong>&quot;muy relevante&quot;<\/strong> a la hora de evaluarlas, junto con las <strong>&quot;regulaciones legales y los aspectos sociales&quot;<\/strong>. Por este motivo, desde la Comisi\u00f3n de \u00c9tica de la AEGH se ha <strong>publicado un an\u00e1lisis<\/strong>\u00a0de las <strong>circunstancias tecnol\u00f3gicas y sociales<\/strong>, los <strong>aspectos \u00e9ticos<\/strong>, las <strong>regulaciones<\/strong> <strong>legales<\/strong> y las <strong>recomendaciones internacionales<\/strong> por la <strong>buena pr\u00e1ctica deontol\u00f3gica<\/strong> por este tipo de tests.<\/p>\n<p>Las <strong>pruebas farmacogen\u00e9ticas<\/strong> podr\u00edan ser <strong>ofertadas al farmac\u00e9utico<\/strong>, y en este caso \u201clo interesante, es que se pueda <strong>discernir<\/strong> realmente<strong> si son v\u00e1lidas y \u00fatiles<\/strong> cl\u00ednicamente\u201d, aseguraba Teresa P\u00e0mpols. Para su buen uso, el farmac\u00e9utico deber\u00eda asegurarse de que hay un <strong>consentimiento informado<\/strong>, informarse de los <strong>beneficios y riesgos<\/strong> e intentar ponerse en contacto con un profesional para tener\u00a0\u00a0<strong>asesoramiento gen\u00e9tico<\/strong>. \u201cEl<strong>ofrecimiento de pruebas sin supervisi\u00f3n m\u00e9dica<\/strong>, <strong>consentimiento informado<\/strong> ni <strong>asesoramiento gen\u00e9tico<\/strong> independiente est\u00e1<strong> en contra de todas las buenas pr\u00e1cticas deontol\u00f3gicas<\/strong> que promueven las sociedades cient\u00edficas internacionales\u201d, concluy\u00f3 P\u00e0mpols.<\/p>\n<p><strong>Otras publicaciones de inter\u00e9s:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/blog.cofb.cat\/farmacogenetica-nivell-avancat-cofb\/\" target=\"_blank\" rel=\"noopener\">Farmacogen\u00e9tica de nivel avanzado en el COFB (Mayo 2018)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/farmacogenetica-farmacia-comunitaria-la-seva-relacio-explicada-per-experts\/\" target=\"_blank\" rel=\"noopener\">Farmacogen\u00e9tica y farmacia comunitaria: su relaci\u00f3n explicada por expertos (Noviembre 2017)<\/a><\/li>\n<li><a href=\"https:\/\/blog.cofb.cat\/consell-nutricional-farmaceutic-prevencio-malalties-neurologiques-video-entrevistes-als-drs-pascual-leone-emili-ros\/\" target=\"_blank\" rel=\"noopener\">El consejo nutricional del farmac\u00e9utico en la prevenci\u00f3n de enfermedades neurol\u00f3gicas. [V\u00eddeo entrevistas a los Dres. Pascual-Leone y Emili Ros] (Enero 2020)<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>El pasado 29 de enero el COFB acogi\u00f3 una nueva tertulia de actualidad titulada &quot;Testemos los tests gen\u00e9ticos&quot;. En una sesi\u00f3n moderada por Luisa Juan, vocal de An\u00e1lisis Cl\u00ednicos del COFB, los ponentes fueron el doctor Manel Rabanal, jefe de la Secci\u00f3n de Vigilancia y Publicidad de los Medicamentos del Departamento de Salud de la [\u2026]<\/p>","protected":false},"author":1,"featured_media":50424,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[3970,3971,311,321,741,3972,3973,2708,3974,3975,3976,3977,3978,3979,140,141,3980,3981,3982],"class_list":["post-49684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-assessorament-i-consell-genetic","tag-consell-genetic","tag-departament-de-salut","tag-farmacogenetica","tag-hospital-clinic","tag-legalitat","tag-manel-rabanal","tag-proves-diagnostiques","tag-proves-farmacogenetiques","tag-proves-genetiques","tag-publicitat-de-medicaments","tag-resposta-als-medicaments","tag-supervisio-professional","tag-teresa-pampols","tag-tertulia-dactualitat","tag-tertulies-dactualitat","tag-test-genetic","tag-tests-farmacogenetics","tag-tests-genetics"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Quin paper pot tenir el farmac\u00e8utic en l&#039;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d&#039;actualitat\u00a0titulada &quot;Testem els tests gen\u00e8tics&quot;. Finalitzat l&#039;acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quin paper pot tenir el farmac\u00e8utic en l&#039;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d&#039;actualitat\u00a0titulada &quot;Testem els tests gen\u00e8tics&quot;. Finalitzat l&#039;acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-10T17:41:41+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Quin paper pot tenir el farmac\u00e8utic en l&#8217;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols]\",\"datePublished\":\"2020-03-10T17:41:41+00:00\",\"dateModified\":\"2020-03-10T17:41:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\"},\"wordCount\":967,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"assessorament i consell gen\u00e8tic\",\"consell gen\u00e8tic\",\"Departament de Salut\",\"farmacogen\u00e8tica\",\"Hospital Cl\u00ednic\",\"legalitat\",\"Manel Rabanal\",\"proves diagn\u00f2stiques\",\"proves farmacogen\u00e8tiques\",\"proves gen\u00e8tiques\",\"publicitat de medicaments\",\"resposta als medicaments\",\"supervisi\u00f3 professional\",\"Teresa P\u00e0mpols\",\"tert\u00falia d'actualitat\",\"tert\u00falies d'actualitat\",\"Test gen\u00e8tic\",\"tests farmacogen\u00e8tics\",\"tests gen\u00e8tics\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\",\"name\":\"Quin paper pot tenir el farmac\u00e8utic en l'\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-03-10T17:41:41+00:00\",\"dateModified\":\"2020-03-10T17:41:41+00:00\",\"description\":\"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d'actualitat\u00a0titulada \\\"Testem els tests gen\u00e8tics\\\". Finalitzat l'acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quin paper pot tenir el farmac\u00e8utic en l&#8217;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols]\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quin paper pot tenir el farmac\u00e8utic en l'\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d'actualitat\u00a0titulada \"Testem els tests gen\u00e8tics\". Finalitzat l'acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/","og_locale":"es_ES","og_type":"article","og_title":"Quin paper pot tenir el farmac\u00e8utic en l'\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d'actualitat\u00a0titulada \"Testem els tests gen\u00e8tics\". Finalitzat l'acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.","og_url":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2020-03-10T17:41:41+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Quin paper pot tenir el farmac\u00e8utic en l&#8217;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols]","datePublished":"2020-03-10T17:41:41+00:00","dateModified":"2020-03-10T17:41:41+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/"},"wordCount":967,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage"},"thumbnailUrl":"","keywords":["assessorament i consell gen\u00e8tic","consell gen\u00e8tic","Departament de Salut","farmacogen\u00e8tica","Hospital Cl\u00ednic","legalitat","Manel Rabanal","proves diagn\u00f2stiques","proves farmacogen\u00e8tiques","proves gen\u00e8tiques","publicitat de medicaments","resposta als medicaments","supervisi\u00f3 professional","Teresa P\u00e0mpols","tert\u00falia d'actualitat","tert\u00falies d'actualitat","Test gen\u00e8tic","tests farmacogen\u00e8tics","tests gen\u00e8tics"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/","url":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/","name":"Quin paper pot tenir el farmac\u00e8utic en l'\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols] - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-03-10T17:41:41+00:00","dateModified":"2020-03-10T17:41:41+00:00","description":"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d'actualitat\u00a0titulada \"Testem els tests gen\u00e8tics\". Finalitzat l'acte, vam poder parlar amb el Dr. Rabanal i la Dra. P\u00e0mpols sobre els tests farmacogen\u00e8tics, el marc legal que els afecta i les seves connotacions \u00e8tiques.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2020\/03\/10\/quin-paper-pot-tenir-el-farmaceutic-en-lambit-de-la-farmacogenetica-video-entrevistes-al-dr-manel-rabanal-i-la-dra-teresa-pampols\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Quin paper pot tenir el farmac\u00e8utic en l&#8217;\u00e0mbit dels tests gen\u00e8tics? [V\u00eddeo entrevista al Dr. Manel Rabanal i la Dra. Teresa P\u00e0mpols]"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 29 de gener el COFB va acollir una nova\u00a0tert\u00falia d&#8217;actualitat\u00a0titulada &#8220;Testem els tests gen\u00e8tics&#8220;. En una sessi\u00f3 moderada per Llu\u00efsa Juan, vocal d&#8217;An\u00e0lisis Cl\u00edniques del COFB, els ponents van ser el doctor\u00a0Manel Rabanal, cap de la\u00a0Secci\u00f3 de Vigil\u00e0ncia i Publicitat dels Medicaments del Departament de Salut de la [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=49684"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/49684\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=49684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=49684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=49684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}